Skip to main content

May 2017

Visioneering Technologies, Inc.

Visioneering Technologies, Inc.
A$33m
Australia Flag US Flag

Visioneering Technologies, Inc.

Lead Manager (IPO)
Healthcare Equity Capital Markets

Canaccord Genuity acts as Lead Manager and Underwriter to Visioneering Technologies, Inc. on its A$33.3 Million Initial Public Offering

Canaccord Genuity is pleased to announce the completion of an initial public offering by Visioneering Technologies, Inc. (“Visioneering”) (ASX:VTI) on the ASX with a market capitalisation of A$88.2m.

The IPO raised gross proceeds of A$33.3 million at an issue price of A$0.42 per share. Canaccord Genuity acted as Lead Manager and Underwriter to the IPO.

Canaccord Genuity also acted as Lead Manager to Visioneering’s pre-IPO capital raising of A$13.5m in the 6 months leading up to the IPO.

Visioneering is a US-based medical device company focused on the design, manufacture, sale and distribution of its NaturalVue Multifocal daily disposable contact lenses for adults with Presbyopia (age-related loss of near vision) and children with Myopia (nearsightedness).